Rhea Dodd Archives
Vanderbilt-Ingram Cancer Center patient first for new cell engineering platform
Feb. 5, 2020—Rhea Dodd is the first patient treated with an experimental cancer vaccine derived from a completely new cell engineering platform.
Feb. 5, 2020—Rhea Dodd is the first patient treated with an experimental cancer vaccine derived from a completely new cell engineering platform.
©
Vanderbilt University Medical Center · All rights reserved.
Vanderbilt University Medical Center is committed to principles of equal opportunity and affirmative action.
Vanderbilt®, Vanderbilt University Medical Center®, V Oak Leaf Design®, Monroe Carell Jr. Children’s Hospital at Vanderbilt® and Vanderbilt Health® are trademarks of The Vanderbilt University.